CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 54 filers reported holding CIDARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,800 | -31.4% | 20,000 | -17.5% | 0.00% | – |
| Q2 2023 | $27,404 | -79.4% | 24,251 | -76.8% | 0.00% | – |
| Q1 2023 | $132,716 | +137.0% | 104,501 | +135.0% | 0.00% | – |
| Q4 2021 | $56,000 | -52.5% | 44,472 | -15.6% | 0.00% | – |
| Q3 2021 | $118,000 | +29.7% | 52,700 | +17.1% | 0.00% | – |
| Q2 2021 | $91,000 | -50.5% | 45,000 | -30.6% | 0.00% | – |
| Q3 2020 | $184,000 | -46.2% | 64,800 | -30.1% | 0.00% | – |
| Q2 2020 | $342,000 | +100.0% | 92,700 | +34.1% | 0.00% | – |
| Q1 2020 | $171,000 | +338.5% | 69,137 | +587.5% | 0.00% | – |
| Q4 2019 | $39,000 | +56.0% | 10,057 | -21.2% | 0.00% | – |
| Q3 2019 | $25,000 | -74.5% | 12,768 | -42.7% | 0.00% | – |
| Q3 2018 | $98,000 | -21.6% | 22,300 | -28.8% | 0.00% | – |
| Q1 2018 | $125,000 | -64.3% | 31,300 | -32.8% | 0.00% | – |
| Q2 2017 | $350,000 | +66.7% | 46,610 | +130.6% | 0.00% | – |
| Q4 2016 | $210,000 | +101.9% | 20,213 | +101.1% | 0.00% | – |
| Q2 2016 | $104,000 | – | 10,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |